CAXTON ASSOCIATES LP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$463,263
+166.1%
152,389
+187.9%
0.06%
+146.2%
Q2 2023$174,123
-62.8%
52,925
-21.8%
0.03%
-16.1%
Q4 2022$468,110
+9.4%
67,6460.0%0.03%
-45.6%
Q3 2022$428,000
-53.0%
67,646
-69.3%
0.06%
-36.0%
Q2 2022$911,000
+462.3%
220,154
+559.6%
0.09%
+584.6%
Q1 2022$162,000
-82.3%
33,376
-63.7%
0.01%
-86.0%
Q4 2021$917,00091,8200.09%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders